SAMEER JHAVAR to Humans
This is a "connection" page, showing publications SAMEER JHAVAR has written about Humans.
Connection Strength
0.179
-
Improved local control in p16 negative oropharyngeal cancers with hypermethylated MGMT. Radiother Oncol. 2021 04; 157:234-240.
Score: 0.019
-
Risk factors for locoregional relapse after radical nephrectomy. Asia Pac J Clin Oncol. 2018 Jun; 14(3):192-197.
Score: 0.015
-
Intensity modulated radiation therapy after extra-pleural pneumonectomy for malignant pleural mesothelioma is feasible without fatal pulmonary toxicity and provides good survival. Asia Pac J Clin Oncol. 2018 Apr; 14(2):e88-e94.
Score: 0.014
-
Durability of Artificial Urinary Sphincter With Prior Radiation Therapy. Clin Genitourin Cancer. 2017 04; 15(2):e175-e180.
Score: 0.014
-
Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer. BJU Int. 2009 May; 103(9):1256-69.
Score: 0.008
-
Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance. Prostate Cancer Prostatic Dis. 2009; 12(2):143-7.
Score: 0.008
-
Detection of TMPRSS2-ERG translocations in human prostate cancer by expression profiling using GeneChip Human Exon 1.0 ST arrays. J Mol Diagn. 2008 Jan; 10(1):50-7.
Score: 0.008
-
Mechanisms of Disease: biomarkers and molecular targets from microarray gene expression studies in prostate cancer. Nat Clin Pract Urol. 2007 Dec; 4(12):677-87.
Score: 0.008
-
Construction of tissue microarrays from prostate needle biopsy specimens. Br J Cancer. 2005 Aug 22; 93(4):478-82.
Score: 0.006
-
Processing of radical prostatectomy specimens for correlation of data from histopathological, molecular biological, and radiological studies: a new whole organ technique. J Clin Pathol. 2005 May; 58(5):504-8.
Score: 0.006
-
Glutathione S-transferase M1 or T1 null genotype as a risk factor for developing multiple primary neoplasms in the upper aero-digestive tract, in Indian males using tobacco. Oral Oncol. 2004 Jan; 40(1):84-91.
Score: 0.006
-
Holmium Laser Enucleation of Prostate in Patients with Pre-Existing Localized Prostate Cancer, Dual Center Study. J Endourol. 2023 03; 37(3):330-334.
Score: 0.005
-
Ad Astra - telomeres in space! Int J Radiat Biol. 2022; 98(3):395-403.
Score: 0.005
-
Primary extranodal mucosa associated lymphoid tissue (MALT) lymphoma of the prostate. Leuk Lymphoma. 2001 Apr; 41(3-4):445-9.
Score: 0.005
-
To B(iopsy) or not to B(iopsy). J Cancer Res Ther. 2017 Oct-Dec; 13(6):1065-1067.
Score: 0.004
-
Single fraction spine stereotactic ablative body radiotherapy with volumetric modulated arc therapy. J Neurooncol. 2017 05; 133(1):165-172.
Score: 0.004
-
Congenital B cell lymphocytosis explained by novel germline CARD11 mutations. J Exp Med. 2012 Nov 19; 209(12):2247-61.
Score: 0.003
-
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature. 2012 Oct 04; 490(7418):116-20.
Score: 0.003
-
Oncogenically active MYD88 mutations in human lymphoma. Nature. 2011 Feb 03; 470(7332):115-9.
Score: 0.002
-
Multicentric breast cancer: clonality and prognostic studies. Breast Cancer Res Treat. 2011 Oct; 129(3):703-16.
Score: 0.002
-
High-density tissue microarrays from prostate needle biopsies. J Clin Pathol. 2011 Jan; 64(1):88-90.
Score: 0.002
-
The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine. PLoS One. 2010 Oct 13; 5(10):e13363.
Score: 0.002
-
Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis. Br J Cancer. 2010 Sep 07; 103(6):918-24.
Score: 0.002
-
The carrier clinic: an evaluation of a novel clinic dedicated to the follow-up of BRCA1 and BRCA2 carriers--implications for oncogenetics practice. J Med Genet. 2010 Jul; 47(7):486-91.
Score: 0.002
-
Multiple loci on 8q24 associated with prostate cancer susceptibility. Nat Genet. 2009 Oct; 41(10):1058-60.
Score: 0.002
-
An improved method for constructing tissue microarrays from prostate needle biopsy specimens. J Clin Pathol. 2009 Aug; 62(8):694-8.
Score: 0.002
-
Dynamic contrast-enhanced MRI for prostate cancer localization. Br J Radiol. 2009 Feb; 82(974):148-56.
Score: 0.002
-
Identification of new genetic risk factors for prostate cancer. Asian J Androl. 2009 Jan; 11(1):49-55.
Score: 0.002
-
TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer. Br J Cancer. 2008 Dec 02; 99(11):1849-58.
Score: 0.002
-
Correlation of diffusion-weighted MRI with whole mount radical prostatectomy specimens. Br J Radiol. 2008 Jun; 81(966):456-62.
Score: 0.002
-
Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study. Lancet Oncol. 2008 Apr; 9(4):342-51.
Score: 0.002
-
Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet. 2008 Mar; 40(3):316-21.
Score: 0.002
-
Complex patterns of ETS gene alteration arise during cancer development in the human prostate. Oncogene. 2008 Mar 27; 27(14):1993-2003.
Score: 0.002
-
Diversity of TMPRSS2-ERG fusion transcripts in the human prostate. Oncogene. 2007 Apr 19; 26(18):2667-73.
Score: 0.002
-
Genotype phenotype correlation in Li-Fraumeni syndrome kindreds and its implications for management. Fam Cancer. 2006; 5(2):129-33.
Score: 0.002
-
Macrophage scavenger receptor 1 999C>T (R293X) mutation and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2005 Feb; 14(2):397-402.
Score: 0.002
-
Expression analysis onto microarrays of randomly selected cDNA clones highlights HOXB13 as a marker of human prostate cancer. Br J Cancer. 2005 Jan 31; 92(2):376-81.
Score: 0.002
-
Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome. Oncogene. 2004 Aug 05; 23(35):5871-9.
Score: 0.002